Article Text

Download PDFPDF
Original article
Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up
  1. Robert V Bryant,
  2. Daniel C Burger,
  3. Joseph Delo,
  4. Alissa J Walsh,
  5. Sally Thomas,
  6. Axel von Herbay,
  7. Otto C Buchel,
  8. Lydia White,
  9. Oliver Brain,
  10. Satish Keshav,
  11. Bryan F Warren,
  12. Simon P L Travis
  1. Translational Gastroenterology Unit and Department of Cellular Pathology, John Radcliffe Hospital, Oxford, UK
  1. Correspondence to Dr Simon PL Travis, Translational Gastroenterology Unit, John Radcliffe Hospital, Oxford OX3 9DU, UK; simon.travis{at}


Background Endoscopic mucosal healing is an established treatment target for UC, yet the value of achieving histological remission remains unclear.

Aims To evaluate histological remission compared to endoscopic mucosal healing for predicting patient outcomes in UC.

Methods Blinded assessment of endoscopic and histological measures of disease activity was performed on patients with established UC at baseline. Concordance and prognostic values of endoscopic mucosal healing (defined by Baron score ≤1) and histological remission (defined by Truelove and Richards’ index) for predicting outcomes of corticosteroid use, hospitalisation and colectomy were determined over a median 6 years follow-up, including κ statistics and Cox regression multivariate analysis.

Results 91 patients with UC were followed up for a median 72 months (IQR 54–75 months). Overall, concordance between endoscopic and histological remission was moderate (κ=0.56, 95% CI 0.36 to 0.77); 24% patients had persistent inflammation despite endoscopic remission. Histological remission predicted corticosteroid use and acute severe colitis requiring hospitalisation over the follow-up period (HR 0.42 (0.2 to 0.9), p=0.02; HR 0.21 (0.1 to 0.7), p=0.02; respectively), whereas endoscopic mucosal healing did not (HR 0.86, 95% CI 0.5 to 1.7, p0.65; HR 0.83 95% CI 0.3 to 2.4, p0.74; respectively).

Conclusions Histological remission is a target distinct from endoscopic mucosal healing in UC and better predicts lower rates of corticosteroid use and acute severe colitis requiring hospitalisation, over a median of 6 years of follow-up. Our findings support the inclusion of histological indices in both UC clinical trials and practice, towards a target of ‘complete remission’.


Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.